💊 “Novelix Pharma: From Dal-Chawal Trader to Pharma Pretender — A ₹122 Cr Mystery”

1. At a Glance

Novelix Pharma is a ₹122 Cr microcap listed on BSE, claiming to operate in “pharma retail & distribution.” But the business history includes food trading, real estate, and investing in shares. Recent name change, open offers, board shuffles, and zero clarity on actual operations. Profitable? Barely. Investable? LOL.

2. Intro with Hook

It started as Trimurthi Ltd — traded food grains, dabbled in property, invested in shares.

Now it’s called Novelix Pharmaceuticals.

Here’s the twist:

• 12-month EPS = ₹0.03
• P/E = 1,522x 🫣
• ROE = 0.64%
• Debt: Zero ✅
• Cash from operations: -₹13 Cr ❌

And yet… stock is up 146% YoY. Welcome to smallcap India — where narratives moon faster than numbers.

3. WTF Do They Even Do? (Business Model)

Their website says “pharma distribution and retail.”

Their financials suggest:

• 📦 Food trading
• 📉 Share investments
• 🏠 Land speculation

Key issues:

• No evidence of branded product lines
• No MRs, no IPs, no patents
• Revenue recently jumped but sources unclear

In short: they sell “stuff.” But you won’t find it on 1mg.

4. Financials Overview – Profit, Margins, ROE, Growth